Implantable arterial port-related bloodstream infection in patients with primary or metastatic hepatic malignancies

被引:0
|
作者
Honda, Hitoshi [1 ]
Sakurai, Yasuo [2 ]
Kang, Jong-Hon [3 ]
Nakamura, Tadahiro [1 ]
Matsuura, Hirotaka [1 ]
Warren, David K. [4 ]
机构
[1] Teine Keijinkai Med Ctr, Dept Gen Internal Med & Infect Dis, Sapporo, Hokkaido 0068555, Japan
[2] Teine Keijinkai Med Ctr, Dept Radiol, Sapporo, Hokkaido 0068555, Japan
[3] Teine Keijinkai Med Ctr, Ctr Gastroenterol, Sapporo, Hokkaido 0068555, Japan
[4] Washington Univ, Sch Med, Dept Internal Med, Div Infect Dis, St Louis, MO 63110 USA
关键词
Implantable arterial port; Hepatic malignancies; Port-related bloodstream infection; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; LIVER METASTASES; CHEMOTHERAPY; INFUSION;
D O I
10.1016/j.ajic.2013.01.018
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The incidence of implantable arterial post-related bloodstream infections (IAP-RBSI) among patients with unresectable hepatic malignancies is not well defined. We reviewed the 9-year incidence of implantable arterial post-related bloodstream infections in patients with hepatic malignancies, at a tertiary care center in Japan. The incidence was 1.9 infections per 10,000 catheter-days. Copyright (C) 2013 by the Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:930 / 932
页数:3
相关论文
共 50 条
  • [31] Prognostication Systems as Applied to Primary and Metastatic Hepatic Malignancies
    Cho, Clifford S.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 24 (01) : 41 - +
  • [32] CHRONIC HEPATIC ARTERY INFUSION THERAPY OF PRIMARY AND METASTATIC HEPATIC MALIGNANCIES
    REED, ML
    VAITKEVICIUS, VK
    ANNALS OF INTERNAL MEDICINE, 1969, 70 (05) : 1106 - +
  • [33] THE INCIDENCE AND RISK FACTORS OF PORT-RELATED INFECTIONS IN ADULT PATIENTS WITH HEMATOLOGICAL MALIGNANCY
    Yildiz, A.
    Albayrak, M.
    Okutan, H.
    Ergun, O.
    Sahin, O.
    Ozturk, C. Pala
    Ozturk, H. Afacan
    Gunes, G.
    Tekoluk, M.
    LEUKEMIA RESEARCH, 2017, 61 : S37 - S37
  • [34] HEPATIC ARTERIAL CHEMOTHERAPY FOR PRIMARY AND METASTATIC LIVER CANCERS
    ENSMINGER, W
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 23 : S68 - S73
  • [35] The Profile of Microorganisms Responsible for Port-Related Bacteremia in Pediatric Hemato-Oncological Patients
    Gowin, Ewelina
    swiatek-Koscielna, Bogna
    Mankowski, Przemyslaw
    Januszkiewicz-Lewandowska, Danuta
    CANCER CONTROL, 2020, 27 (01)
  • [36] Catheter-related bloodstream infections in patients with oncohaematological malignancies
    Carmona-Torre, Francisco
    Yuste, Jose R.
    Castejon, Sandra
    Ramos, Ana
    Del Pozo, Jose L.
    LANCET INFECTIOUS DISEASES, 2017, 17 (02): : 139 - 140
  • [37] Hepatic arterial chemotherapy in metastatic colorectal patients
    Kemeny, NE
    Ron, IG
    SEMINARS IN ONCOLOGY, 1999, 26 (05) : 524 - 535
  • [38] Predictors of Bloodstream Infection in Patients Presenting With Cardiovascular Implantable Electronic Device Pocket Infection
    Garrigos, Zerelda Esquer
    George, Merit P.
    Khalil, Sarwat
    Vijayvargiya, Prakhar
    Abu Saleh, Omar M.
    Friedman, Paul A.
    Steckelberg, James M.
    DeSimone, Daniel C.
    Wilson, Walter R.
    Baddour, Larry M.
    Sohail, M. Rizwan
    OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (04):
  • [39] Use of Universal 16S rRNA Gene PCR as a Diagnostic Tool for Venous Access Port-Related Bloodstream Infections
    Guembe, M.
    Marin, M.
    Martin-Rabadan, P.
    Echenagusia, A.
    Camunez, F.
    Rodriguez-Rosales, G.
    Simo, G.
    Echenagusia, M.
    Bouza, E.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (03) : 799 - 804
  • [40] A totally implantable venous access port associated with bloodstream infection caused by Mycobacterium fortuitum A case report
    Ye, Huifen
    Zeng, Junshao
    Qin, Wenzhou
    Yang, Zhao
    Yang, Ling
    Wu, Zhitong
    Du, Guinian
    MEDICINE, 2018, 97 (29)